Browsing by Author "Torres Montes, Paula Javiera"
Now showing 1 - 9 of 9
Results Per Page
Sort Options
- ItemAndrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis(2017) Cabrera, Daniel; Wree, Alexander; Povero, Davide; Solís, Nancy; Hernández, Alejandra; Pizarro Rojas, Margarita Alicia; Moshage, Han; Torres Montes, Paula Javiera; Feldstein, Ariel E.; Cabello Verrugio, Claudio Alejandro; Brandan, Enrique; Barrera Martínez, Francisco Javier; Arab Verdugo, Juan Pablo; Arrese Jiménez, Marco
- ItemColitis de Crohn: Resultados del tratamiento quirúrgico y evolución alejada(2018) Imigo Gueregat, Felipe Andrés; Molina Pezoa, María Elena; Álvarez Lobos, Manuel; Quintana Villar, Carlos; Klaassen Lobos, Julieta Isabel; Torres Montes, Paula Javiera; Duarte, Ignacio; Bellolio R., Felipe; Zúñiga Díaz, Alvaro
- ItemDiet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1(2016) Cabrera, D.; Ruiz, A.; Cabello Verrugio, Claudio Alejandro; Brandan, Enrique; Estrada, L.; Pizarro, M.; Solis, N.; Torres Montes, Paula Javiera; Barrera Martínez, Francisco José; Arrese Jiménez, Marco
- ItemHepatocellular carcinoma in identical twins in Chile: case report(2016) Caglevic, C.; Silva, S.; Mahave, M.; Torres Montes, Paula Javiera; Rolfo, C.; Gallardo, J.; Carrasco, P.Liver cancer is the second leading cause of cancer death worldwide, with hepatocellular carcinoma (HCC) being the most common type of primary malignant liver tumour, with a typically poor prognosis, growing incidence and a well-documented relationship with chronic inflammation factors of the liver tissue. Despite the fact that family medical history has been identified as a risk factor for the development of HCC, its significance in terms of etiopathogenesis and prognosis is not well documented. With a view to contributing to this discussion, we will report the clinical case of two identical twins with HCC, both diagnosed within a short period of time, by providing relevant clinical data, and relating this to other medical literature reports that could contribute to a deeper understanding of this illness.
- Item¿Influye el medio de preservación del injerto en los resultados y costos del trasplante hepático de donante fallecido? Comparación de dos soluciones de preservación(2014) Martínez Castillo, Jorge; Bächler, Jean P.; Moisan Paravic, Fabrizio Robertino; Torres Montes, Paula Javiera; Duarte, Ignacio; Pérez Ayuso, Rosa María; Benítez Gajardo, Carlos Esteban; Arrese, Marco; Domínguez, Pilar; Guerra Castro, Juan Francisco; Jarufe Cassis, NicolásBackground: Preservation solutions are critical for organ transplantation. In liver transplant (LT), the solution developed by the University Of Wisconsin (UW) is the gold-standard to perfuse deceased brain death donor (DBD) grafts. Histidine-Tryptophan-Ketoglutarate (HTK), formerly a cardioplegic infusion, has been also used in solid organ transplantation. Aim: To compare the outcomes of LT in our center using either HTK or UW solution. Patients and Methods: Retrospective study including 93 LT DBD liver grafts in 89 patients transplanted between March 1994 and July 2010. Forty-eight grafts were preserved with UW and 45 with HTK. Donor and recipient demographics, total infused volume, cold ischemia time, post-reperfusion biopsy, liver function tests, incidence of biliary complications, acute rejection and 12-month graft and patient survival were assessed. Preservation solution costs per liver graft were also recorded. Results: Donor and recipient demographics were similar. When comparing UW and HTK, no differences were observed in cold ischemia time (9.6 ± 3 and 8.7 ± 2 h respectively, p = 0.23), biliary complications, the incidence of acute rejection, primary or delayed graft dysfunction. Histology on post-reperfusion biopsies revealed no differences between groups. The infused volume was significantly higher with HTK than with UW (9 (5-16) and 6 (3-11) l, p < 0.001). The cost per procurement was remarkably lower using HTK. Conclusions: Perfusion of DBD liver grafts with HTK is clinically equivalent to UW, with a significant cost reduction.
- ItemPeptic Ulcer Disease in Helicobacter pylori-Infected Children : Clinical Findings and Mucosal Immune Response(2014) Hernández C.; Serrano Honeyman, Carolina; Einisman, H.; Villagrán, A.; Peña Villegas, Alfredo Javier; Duarte, Ignacio; Torres Montes, Paula Javiera; Riera Cassorla, Francisca Paz; Harris D., Paul R.; Hernández C.; Serrano Honeyman, Carolina; Einisman, H.; Villagrán, A.; Peña Villegas, Alfredo Javier; Duarte, Ignacio; Torres Montes, Paula Javiera; Riera Cassorla, Francisca Paz; Harris D., Paul R.
- ItemPersistent salmonella enterica serovar typhimurium infection increases the susceptibility of mice to develop intestinal inflammation(2018) Schultz, B.; Salazar, G.; Paduro, C.; Pardo Roa, Catalina; Pizarro, D.; Salazar Echegarai, Francisco Javier; Torres Montes, Paula Javiera; Riedel, C.; Kalergis Parra, Alexis Mikes; Álvarez Lobos, Manuel; Bueno Ramírez, Susan
- ItemRecomendaciones sobre el manejo del cáncer de páncreas tipo adenocarcinoma en Latinoamérica. Reunión del Consenso del Simposio Latinoamericano de Gastroenterología Oncológica (SLAGO) y de la Asociación Ibero Latinoamericana de Terapia Radiante (ALATRO), Viña del Mar, Chile 2015(2016) Caglevic, Christian; Gallardo, Jorge; De la Torre, Marcela; Mahave, Mauricio; Müller, Bettina; Solé, Sebastián; Moscoso, Yuri; De La Fuente, Hernán; Roa Strauch, Juan Carlos Enrique; Torres Montes, Paula Javiera
- ItemTrasplante hepático exitoso en un paciente portador del Virus de la Inmunodeficiencia Humana (VIH): casos clínicos(2018) Guerra Castro, Juan Francisco; Troncoso T., Andrés; Ceballos, María Elena; Arrese Jiménez, Marco; Barrera Martínez, Francisco José; Norero, Blanca; Soza, Alejandro; Rivas, Violeta; Wolff, Rodrigo; Arias, Alejandra; Cancino, Alejandra; Torres Montes, Paula Javiera; Briceño, Eduardo; Jarufe Cassis, Nicolás; Martínez Castillo, Jorge; Benítez, Carlos